Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSUBREAST
NCT07254221Phase 4Not yet recruiting
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2026
- Primary completion
- Apr 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in anthracycline-induced cardiotoxicity, sponsored by Shiraz University of Medical Sciences. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
rosuvastatin
03
Conditions
anthracycline-induced cardiotoxicity
Beyond the preview
Go deeper on NCT07254221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07254221.